Lexiscan approved for MPI testing Lexiscan (regadenoson injection, from Astellas), a pharmacologic stress agent, is now available for use in radionuclide myocardial perfusion imaging (MPI) for ...

Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial Monday December 4, 7:00 am ET - New drug application planned for mid-2007 - PALO ALTO, Calif. and DEERFIELD, Ill., Dec. 4 -- CV ...

Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. Dr. Reddy's is offering ...

CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan Injection; Stocks Rise PALO ALTO, Calif., April 15 -- CV Therapeutics, Inc. announced today ...

Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. Hikma is offering Regadenoson ...

Already used in Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) for adult patients, Rapiscan is now approved for use in stress Cardiac Magnetic Resonance Imaging ...

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent ...